Custom Implants for Complex Acetabular Defects Provide Excellent Mid- to Long-Term Survivorship

The management of massive acetabular bone loss in revision total hip arthroplasty (THA) continues to challenge even the most experienced reconstructive surgeons. While biologic solutions such as structural allograft and cage constructs have declined in favor, and modular porous-metal augments have transformed the field, a subset of patients with Paprosky type-3B defects—particularly those complicated by pelvic discontinuity—still challenge current reconstructive techniques1–3. The emergence of custom-made acetabular implants (CMAIs) has filled this gap, and yet, long-term evidence remains sparse4,5. The study by Di Laura et al. therefore represents an important and timely contribution. A notable strength of this work is the minimum 5-year (mean, 7-year) follow-up, offering the longest continuous data set available for a single-manufacturer custom-made implant. The authors report exceptional implant survivorship (96.3% at 9 years) and robust functional gains, including a median Oxford Hip Score improvement from 8 preoperatively to 32 at the previous, mid-term follow-up (p < 0.0001), which was sustained. Most importantly, the authors report that 90% of the patients had radiographic evidence of bone ingrowth—an impressive achievement given the partial implant-bone contact described on initial postoperative computed tomography (CT). Perhaps the most thought-provoking observation is the “adaptive” migration pattern: small, controlled displacements (≤5 mm) limited to the first postoperative year, followed by radiographic stabilization. Rather than reflecting early mechanical compromise, these small adjustments appear to represent progressive seating within a meticulously prepared defect, culminating in osseointegration. This aligns with similar patterns seen with cementless tibial components, where initial implant motion as noted by radiostereometric analysis (RSA) was not associated with failure6. This concept aligns with prior work in CT-based migration analysis7 and suggests that surgeons should interpret minor early migration in this context cautiously, avoiding premature concern when advanced imaging confirms convergence toward stability. I believe a major asset of this study is its postoperative imaging assessment. The authors leverage serial imaging as a way to determine implant stability or migration, bone ingrowth, and potential loosening if encountered. This detailed postoperative assessment is not typically seen with other studies evaluating implants used for severe acetabular defects and could potentially serve as a landmark for future studies. Despite the many strengths, several limitations warrant consideration. As with most studies of custom acetabular components, the single-surgeon design introduces concerns regarding generalizability; the technical skill required for accurate plan execution, defect preparation, and component insertion may not reflect broader practice patterns. However, the use of custom guides facilitates the technical aspects of the procedure. In addition, the modest sample size (n = 30) limits the precision of survivorship estimates and the ability to assess risk factors for failure. That said, the rarity of these defects makes large-scale studies unlikely, and the authors’ series remains among the most comprehensive available. The authors also highlight that initial bone-implant contact averaged only 15%, reflecting the importance of solid mechanical initial fixation to provide stability that will then lead to biologic fixation. The finding that these constructs, despite limited initial support, can achieve long-term biologic fixation is encouraging—and may provide reassurance to surgeons hesitant to adopt custom implants out of concern for inadequate host bone. In the broader context, this work reinforces the role of CMAIs as a durable option for extreme acetabular deficiency. Their findings align with, and extend, recent systematic reviews reporting survivorship percentages in the mid-90s range and acceptable complication profiles5. As the field moves forward, key questions remain: when should modular reconstruction techniques or CMAIs be used, and can we shorten the manufacturing time? This study lays the groundwork for addressing those questions. In summary, Di Laura et al. provide compelling long-term evidence that custom-made acetabular implants deliver durable fixation, sustained function, and acceptable complication rates in the most challenging revision scenarios. Their work strengthens the growing consensus that CMAIs are not merely salvage constructs, but rather, a reliable reconstructive solution when conventional implants reach their limits.